A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-08
DOI
10.1038/s41419-020-03308-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN
- (2019) Liwen Guo et al. FEBS Open Bio
- Delineating the interaction of combretastatin A-4 with αβ tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach
- (2019) Bajarang Vasant Kumbhar et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
- (2019) Anubhab Mukherjee et al. International Journal of Nanomedicine
- Combination Therapy and the Evolution of Resistance: The Theoretical Merits of Synergism and Antagonism in Cancer
- (2018) Elysia C. Saputra et al. CANCER RESEARCH
- High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis
- (2018) Ruochan Chen et al. HEPATOLOGY
- Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
- (2018) Susan E. Logue et al. Nature Communications
- Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
- (2017) Fei Ma et al. MEDICINE
- An autocrine inflammatory forward-feedback loop after chemotherapy withdrawal facilitates the repopulation of drug-resistant breast cancer cells
- (2017) Deyong Jia et al. Cell Death & Disease
- Bridging the divide: preclinical research discrepancies between triple-negative breast cancer cell lines and patient tumors
- (2017) Andrew Sulaiman et al. Oncotarget
- Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma
- (2016) D. Roife et al. CLINICAL CANCER RESEARCH
- Increased cancer stem cell invasion is mediated by myosin IIB and nuclear translocation
- (2016) Dustin Thomas et al. Oncotarget
- The Hippo signaling pathway provides novel anti-cancer drug targets
- (2016) June Sung Bae et al. Oncotarget
- The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4
- (2016) Min Su et al. Scientific Reports
- The Contribution of Angiogenesis to the Process of Metastasis
- (2015) Diane R. Bielenberg et al. CANCER JOURNAL
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
- (2015) Deyong Jia et al. Oncotarget
- Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs
- (2015) Che-Hsin Lee et al. Oncotarget
- Quantitative Analysis of the Enhanced Permeation and Retention (EPR) Effect
- (2015) Andrew D. Wong et al. PLoS One
- Transgenic fluorescent zebrafish Tg(fli1:EGFP)y1 for the identification of vasotoxicity within the zFET
- (2014) Vera Delov et al. AQUATIC TOXICOLOGY
- YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway
- (2014) Y. Zhao et al. CANCER RESEARCH
- Cancer stem cells and tumor metastasis
- (2014) SHUANG LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
- (2014) Suling Liu et al. Stem Cell Reports
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
- (2013) Murielle Mimeault et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
- (2011) Yoko S DeRose et al. NATURE MEDICINE
- Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
- (2011) C. C.-L. Wong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model
- (2010) Cheng-Huang Shen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Zebrafish as a Cancer Model
- (2008) H. Feitsma et al. MOLECULAR CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now